Diminished Immune Surveillance during Histologic Progression of Intraductal Papillary Mucinous Neoplasms Offers a Therapeutic Opportunity for Cancer Interception.
Hernandez S, Parra ER, Uraoka N, Tang X, Shen Y, Qiao W, Jiang M, Zhang S, Mino B, Lu W, Pandurengan R, Haymaker C, Affolter K, Scaife CL, Yip-Schneider M, Schmidt CM, Firpo MA, Mulvihill SJ, Koay EJ, Wang H, Wistuba II, Maitra A, Solis LM, Sen S.
Hernandez S, et al. Among authors: pandurengan r.
Clin Cancer Res. 2022 May 2;28(9):1938-1947. doi: 10.1158/1078-0432.CCR-21-2585.
Clin Cancer Res. 2022.
PMID: 35491652
Free PMC article.